[1. Aekplakorn W. Thai Health 2007 [Internet]. Bangkok: Institute for Population and Social Research Mahidol University; 2007; [cited 2012 June 5]: Available from: http://www.hiso.or.th/hiso/picture/reportHealth/ThaiHealth2007/ENG2007-Health-Indicators5.pdf]Search in Google Scholar
[2. Gurfinkel E, Mautner B. Secondary prevention of coronary artery disease. Flu vaccinations and new evidence of the role of infection in acute coronary syndromes. Rev Esp Cardiol. 2002; 55:1009-12.10.1016/S0300-8932(02)76747-X]Open DOISearch in Google Scholar
[3. Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, et al. Influenza vaccination as secondary prevention for cardiovascular disease; a science advisory from the American Heart Association/ American College of Cardiology. J Am Coll Cardiol. 2006; 48:1498-502.10.1016/j.jacc.2006.09.00417010820]Open DOISearch in Google Scholar
[4. CDC Home [Internet]. Centers for Disease Control and Prevention; 2011; [updated 2012 April 16; cited 2012,June 5]: Available from: http://www.cdc.gov/flu/professionals/acip/]Search in Google Scholar
[5. Smith SC Jr, Allen J, Blair SN, Bonow RO, Brass LM, Fonarow GC, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease. Circulation. 2006; 113:2363-72.10.1161/CIRCULATIONAHA.106.17451616702489]Search in Google Scholar
[6. Nease RF, Kneeland T, O∩onnor GT, Sumner W, Lumpkins C, Shaw L. et al. Variation in patient utilities for outcomes of the management of chronic stable angina implications for clinical practice guidelines. JAMA. 1995; 273:1185-90.10.1001/jama.1995.03520390045031]Search in Google Scholar
[7. National Health Security Office. The annual report of universal health insurance coverage 2009. [Internet]. Bangkok: National Health Security Office, Thailand [cited 2012 June 26]. Available from: http://www.nhso.go.th/FrontEnd/page-about_result.aspx]Search in Google Scholar
[8. Hoerger TJ, Hicks KA, Bethke AD. Health, social, and economics research; technical report: a Markov model of disease progression and cost-effectiveness for type 2 diabetes. NC; 2004.]Search in Google Scholar
[9. Weinstein MC, Coxson PG, Williams LW, Pass TM, Stason WB, Goldman L. Forecasting coronary heart disease incidence, mortality, and cost: the coronary heart disease policy model. AJPH. 1987; 77:1417-26.10.2105/AJPH.77.11.1417]Search in Google Scholar
[10. Board of directors to reduce the risk factors that affect chronic disease. Thailand healthy lifestyle strategic plan 2011-2010: situation of health problem and chronic non-communicable disease result from lifestyle change. Bangkok: Office of the National Economic and Social Development Board/Ministry of Public Health.]Search in Google Scholar
[11. Hunink MG, Goldman L, Tosteson AN, Mittleman MA, Goldman PA, Williams LW, et al. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997; 277:535-42.10.1001/jama.1997.03540310033031]Search in Google Scholar
[12. Keller T, Weeda VB, van Dongen CJ, Levi M. Influenza vaccines for preventing coronary heart disease. Cochrane Database Syst Rev. 2008; 3:CD005050. doi: 10.1002/14651858.CD005050.pub2.]Search in Google Scholar
[13. Praditsuwan R, Assantachai P, Wasi C, Phuthavatana P, Kositanont U. The efficacy and effectiveness of influeza vaccination among Thai elderly persons living in the community. J Med Assoc Thai. 2005; 88: 256-64.]Search in Google Scholar
[14. Nease RF, Kneeland T, O’Connor GT, Sumner W, Lumpkins C, Shaw L, et al. Variation in patient utilities for outcomes of the management of chronic stable angina. JAMA. 1995; 273:1185-90.10.1001/jama.1995.03520390045031]Search in Google Scholar
[15. Hayashino Y, Nagata-Kobayashi S, Morimoto T, Maeda K, Shimbo T, Tsuguya F. Cost-effectiveness of screening CAD in diabetics cost-effectiveness of screening for coronary artery disease in asymptomatic patients with type 2 diabetes and additional atherogenic risk factors. J Gen Intern Med. 2004; 19: 1181-91.10.1111/j.1525-1497.2004.40012.x149259415610328]Open DOISearch in Google Scholar
[16. Tsevat J, Goldman L, Soukup RJ, Lamas GA, Connors KF, Chapin CC, et al. Stability of time-tradeoff utilities in survivors of myocardial infarction. Med Decis Making. 1993; 13:161-5.10.1177/0272989X93013002108483401]Open DOISearch in Google Scholar
[17. Pradas VR, Villar FA, Martinex-Zarate M. Use of European quality of life-5 dimensions (EQ-5D) questionnaire to value the health related quality of life variation because of influenza. Publicado en Gac Sanit. 2009; 23:104-8.]Search in Google Scholar
[18. Anukulsawat P, Sritara P, Teerawattananont Y. Treatment cost of acute myocardial infarction at Ramathibodi Hospital. Thai Heart J. 2006; 16:132-43.]Search in Google Scholar
[19. Simmermana JM, Lertiendumrong J, Dowell SF, Uyeki T, Olsen SJ, Chittaganpitch M, et al. The cost of influenza in Thailand. Vaccine. 2006; 24:4417-26.10.1016/j.vaccine.2005.12.06016621187]Search in Google Scholar
[20. Riewpaiboon A. Standard cost lists for health technology assessment. Bangkok: Health Intervention and Technology Assessment Program; 2009.]Search in Google Scholar
[21. Aungkulanon S, Lertiendumrong. International Health Policy Program, Thailand Presentation [Internet]. Bangkok: International Health Policy Program, Thailand; 2009 Dec 3 [cited 2012 June 26]. Available from: https://ihppthaigov.net/presentation/attachjournal/267/PPT/PPT1.ppt]Search in Google Scholar
[22. Department of Provincial Administration. Ministry of Interior. [Internet]. Bangkok: Department of Provincial Administration. Ministry of Interior: 2011 Dec 31; [cited 2012 June 25]. Available from http://www.dopa.go.th/]Search in Google Scholar
[23. Thailand. Thai Burden of Disease Working Group: 2009/ International Health Policy Program Thailand. Burden of Disease Thailand, 2009. Bangkok: Ministry of Public Health; 2011. ]Search in Google Scholar